{"product_id":"mayo-clinic-hematology-medical-oncology-practice-updates-and-board-review-online-course-2025","title":"Mayo Clinic Hematology \u0026 Medical Oncology Practice Updates and Board Review Online Course 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: clinicians, fellows, residents preparing for the ABIM certification exams or seeking practical updates for daily practice in hematology, oncology\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse opens: 08\/28\/2025\u003c\/p\u003e\n\u003cp\u003eCOURSE DIRECTORS: Kebede H. Begna, M.D., Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.\u003c\/p\u003e\n\u003cp\u003eThis online course offers up-to-date, practical information in hematology and medical oncology for immediate clinical use. It also provides high-yield content to help prepare for the ABIM initial and maintenance certification exams in both specialties.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis activity is appropriate for physicians and resident fellows.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eRecognize evidence-based practices for managing patients with bleeding and\/or clotting disorders.\u003c\/p\u003e\n\u003cp\u003eIdentify appropriate molecular tests, such as next-generation sequencing, for cancer diagnosis.\u003c\/p\u003e\n\u003cp\u003eRecognize how to incorporate the most current cancer treatment options, such as immunotherapy or targeted therapy, into clinical practice.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDuration\u003c\/p\u003e\n\u003cp\u003eLecture Title\u003c\/p\u003e\n\u003cp\u003eSpeaker(s)\u003c\/p\u003e\n\u003cp\u003e0:25:20\u003c\/p\u003e\n\u003cp\u003eEarly Breast Cancer Locoregional Therapy\u003c\/p\u003e\n\u003cp\u003eTina Hieken, M.D.\u003c\/p\u003e\n\u003cp\u003e0:35:08\u003c\/p\u003e\n\u003cp\u003eHER2-Positive Breast Cancer\u003c\/p\u003e\n\u003cp\u003ePooja Advani, M.B.B.S., M.D.\u003c\/p\u003e\n\u003cp\u003e0:34:02\u003c\/p\u003e\n\u003cp\u003eSystemic Therapy for TNBC: Curative \u0026amp; Palliative\u003c\/p\u003e\n\u003cp\u003eRoberto Leon Ferre, M.D.\u003c\/p\u003e\n\u003cp\u003e0:37:40\u003c\/p\u003e\n\u003cp\u003eSystemic Therapy for ER+\/HER2 Breast Cancer Therapy\u003c\/p\u003e\n\u003cp\u003eTufia Haddad, M.D.\u003c\/p\u003e\n\u003cp\u003e0:31:21\u003c\/p\u003e\n\u003cp\u003eManagement of Early-Stage Colorectal Cancer​\u003c\/p\u003e\n\u003cp\u003eJeremy Jones, M.D.\u003c\/p\u003e\n\u003cp\u003e0:34:08\u003c\/p\u003e\n\u003cp\u003eAdvanced Colorectal Cancer (CRC)​\u003c\/p\u003e\n\u003cp\u003eTanios Bekaii-Saab, M.D.\u003c\/p\u003e\n\u003cp\u003e0:35:44\u003c\/p\u003e\n\u003cp\u003eUpper GI Cancer\u003c\/p\u003e\n\u003cp\u003eBassam Sonbol, M.D.\u003c\/p\u003e\n\u003cp\u003e0:29:30\u003c\/p\u003e\n\u003cp\u003eHepatobiliary Cancers\u003c\/p\u003e\n\u003cp\u003eMitesh Borad, M.D.\u003c\/p\u003e\n\u003cp\u003e0:24:32\u003c\/p\u003e\n\u003cp\u003ePancreatic Cancer 2025\u003c\/p\u003e\n\u003cp\u003eRobert McWilliams, M.D.\u003c\/p\u003e\n\u003cp\u003e0:31:10\u003c\/p\u003e\n\u003cp\u003eUpdate on Management of Early Stage NSCLC​\u003c\/p\u003e\n\u003cp\u003eVinicius Ernani, M.D.\u003c\/p\u003e\n\u003cp\u003e0:37:26\u003c\/p\u003e\n\u003cp\u003eAdvanced Stage IV NSCLC\u003c\/p\u003e\n\u003cp\u003eRami Manochakian, M.D.\u003c\/p\u003e\n\u003cp\u003e0:24:33\u003c\/p\u003e\n\u003cp\u003eSmall Cell Lung Cancer\u003c\/p\u003e\n\u003cp\u003eKaushal Parikh, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e0:23:14\u003c\/p\u003e\n\u003cp\u003eOther Thoracic Malignancies​\u003c\/p\u003e\n\u003cp\u003eKonstantinos Leventakos, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e0:33:42\u003c\/p\u003e\n\u003cp\u003eHead and Neck Cancer\u003c\/p\u003e\n\u003cp\u003eKatharine Price, M.D.\u003c\/p\u003e\n\u003cp\u003e0:21:24\u003c\/p\u003e\n\u003cp\u003eNeuro-Oncology\u003c\/p\u003e\n\u003cp\u003eAlyx Porter, M.D.\u003c\/p\u003e\n\u003cp\u003e0:24:05\u003c\/p\u003e\n\u003cp\u003eSarcoma​\u003c\/p\u003e\n\u003cp\u003eSteve Robinson, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e0:28:42\u003c\/p\u003e\n\u003cp\u003eBladder ​ Cancer Update\u003c\/p\u003e\n\u003cp\u003eParminder Singh, M.D.\u003c\/p\u003e\n\u003cp\u003e0:32:57\u003c\/p\u003e\n\u003cp\u003eRCC in 2025: What’s New for the Practicing Oncologist?\u003c\/p\u003e\n\u003cp\u003eYousef Zakharia\u003c\/p\u003e\n\u003cp\u003e0:26:04\u003c\/p\u003e\n\u003cp\u003eGerm Cell Cancers\u003c\/p\u003e\n\u003cp\u003eLance Pagliaro, M.D.\u003c\/p\u003e\n\u003cp\u003e0:33:24\u003c\/p\u003e\n\u003cp\u003eDan Childs, M.D.\u003c\/p\u003e\n\u003cp\u003e0:40:18\u003c\/p\u003e\n\u003cp\u003eOvarian Cancer\u003c\/p\u003e\n\u003cp\u003eAndrea Wahner Hendrickson, M.D.\u003c\/p\u003e\n\u003cp\u003e0:28:42\u003c\/p\u003e\n\u003cp\u003eUpdates in Endocrine Malignancies\u003c\/p\u003e\n\u003cp\u003eMabel Ryder, M.D.\u003c\/p\u003e\n\u003cp\u003e0:26:59\u003c\/p\u003e\n\u003cp\u003eHereditary Cancer Syndromes\u003c\/p\u003e\n\u003cp\u003eSiddhartha Yadav, M.B.B.S., M.D.\u003c\/p\u003e\n\u003cp\u003e0:28:43\u003c\/p\u003e\n\u003cp\u003eTransfusion Medicine for Hematologist\/Medical Oncologist​\u003c\/p\u003e\n\u003cp\u003eJeffrey Winters, M.D.\u003c\/p\u003e\n\u003cp\u003e0:34:13\u003c\/p\u003e\n\u003cp\u003eManagement of Thrombosis in Cancer​\u003c\/p\u003e\n\u003cp\u003eAneel Ashrani, M.D., M.S.\u003c\/p\u003e\n\u003cp\u003e0:30:05\u003c\/p\u003e\n\u003cp\u003ePalliative Care and Symptom Management​\u003c\/p\u003e\n\u003cp\u003eJacob Strand, M.D.\u003c\/p\u003e\n\u003cp\u003e0:23:25\u003c\/p\u003e\n\u003cp\u003eHodgkin Lymphoma\u003c\/p\u003e\n\u003cp\u003eStephen Ansell, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e0:32:04\u003c\/p\u003e\n\u003cp\u003eAggressive B-Cell Lymphoma\u003c\/p\u003e\n\u003cp\u003eGrzegorz Nowakowski, M.D.\u003c\/p\u003e\n\u003cp\u003e0:24:53\u003c\/p\u003e\n\u003cp\u003eChronic Lymphocytic Leukemia\u003c\/p\u003e\n\u003cp\u003eSameer Parikh, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e0:29:58\u003c\/p\u003e\n\u003cp\u003eFollicular and Mantle Cell Lymphoma Update\u003c\/p\u003e\n\u003cp\u003eThomas Witzig, M.D.\u003c\/p\u003e\n\u003cp\u003e0:25:11\u003c\/p\u003e\n\u003cp\u003eOther Indolent Non-Hodgkin Lymphomas\u003c\/p\u003e\n\u003cp\u003eThomas Habermann, M.D.\u003c\/p\u003e\n\u003cp\u003e0:20:55\u003c\/p\u003e\n\u003cp\u003eT cell lymphoma​\u003c\/p\u003e\n\u003cp\u003eAllison Rosenthal, D.O.\u003c\/p\u003e\n\u003cp\u003e0:26:33\u003c\/p\u003e\n\u003cp\u003eMGUS \/ Smoldering Myeloma​\u003c\/p\u003e\n\u003cp\u003eAngela Dispenzieri, M.D.\u003c\/p\u003e\n\u003cp\u003e0:30:59\u003c\/p\u003e\n\u003cp\u003eNewly Diagnosed Multiple Myeloma\u003c\/p\u003e\n\u003cp\u003eVivek Roy, M.D.\u003c\/p\u003e\n\u003cp\u003e0:38:27\u003c\/p\u003e\n\u003cp\u003eCAR-T in Myeloma\u003c\/p\u003e\n\u003cp\u003eYi Lin, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e0:25:53\u003c\/p\u003e\n\u003cp\u003eWaldenström’s Macroglobulinemia and Amyloidosis​\u003c\/p\u003e\n\u003cp\u003eMorie Gertz, M.D.\u003c\/p\u003e\n\u003cp\u003e0:34:40\u003c\/p\u003e\n\u003cp\u003eMyeloproliferative Neoplasms, Mastocytosis, and Eosinophilic Disorders\u003c\/p\u003e\n\u003cp\u003eAyalew Tefferi, M.D.\u003c\/p\u003e\n\u003cp\u003e0:30:10\u003c\/p\u003e\n\u003cp\u003eMyelodysplastic Syndromes and Bone Marrow Failure States – 2025 Updates ​\u003c\/p\u003e\n\u003cp\u003eMrinal Patnaik, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e0:19:22\u003c\/p\u003e\n\u003cp\u003eChronic Myeloid Leukemia ​\u003c\/p\u003e\n\u003cp\u003eKebede Begna, M.D.\u003c\/p\u003e\n\u003cp\u003e0:23:12\u003c\/p\u003e\n\u003cp\u003eAcute Myeloid Leukemia\u003c\/p\u003e\n\u003cp\u003eNaseema Gangat, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e0:33:38\u003c\/p\u003e\n\u003cp\u003eUpdate in Acute Lymphoblastic Leukemia​\u003c\/p\u003e\n\u003cp\u003eMark Litzow, M.D.\u003c\/p\u003e\n\u003cp\u003e0:29:58\u003c\/p\u003e\n\u003cp\u003eTransplantation for Hematologic Disorders Including GVHD​\u003c\/p\u003e\n\u003cp\u003eWilliam Hogan, M.B., B.Ch.\u003c\/p\u003e\n\u003cp\u003e0:27:08\u003c\/p\u003e\n\u003cp\u003eHLH​ Porphyrias \/​ Acquired Thrombocytopenia (ITP)​\u003c\/p\u003e\n\u003cp\u003eAlexandra Wolanskyj-Spinner, M.D.\u003c\/p\u003e\n\u003cp\u003e0:26:46\u003c\/p\u003e\n\u003cp\u003ePlatelet Disorders​\u003c\/p\u003e\n\u003cp\u003eMeera Sridharan, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e0:25:18\u003c\/p\u003e\n\u003cp\u003eCoagulation Factor Disorders: Molecular Basis, Inherited \u0026amp; Acquired Bleeding Disorders ​\u003c\/p\u003e\n\u003cp\u003eRajiv Pruthi, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e0:29:53\u003c\/p\u003e\n\u003cp\u003eHemoglobinopathies\u003c\/p\u003e\n\u003cp\u003eEwa Wysokinska, M.D.\u003c\/p\u003e\n\u003cp\u003e0:26:00\u003c\/p\u003e\n\u003cp\u003eNutritional Anemias and Iron Disorders\u003c\/p\u003e\n\u003cp\u003eRonald Go, M.D.\u003c\/p\u003e\n\u003cp\u003e0:28:54\u003c\/p\u003e\n\u003cp\u003eImmune Hemolytic Anemia ​\u003c\/p\u003e\n\u003cp\u003eSurbhi Shah, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e28:00:23 Content Hours\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405783650500,"sku":null,"price":143.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Mayo-Clinic-Hematology-Medical-Oncology-Practice-Updates-and-Board-Review-Online-Course-2025.jpg?v=1784216099","url":"https:\/\/medicalcoursespro.com\/products\/mayo-clinic-hematology-medical-oncology-practice-updates-and-board-review-online-course-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}